PRE-EMPT: Prevention of Mood Disorders by Folic Acid Supplement. - PRE-EMPT

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-003341-40-GB

Enrollment

200

Registered

2005-10-31

Start date

2004-12-08

Completion date

Unknown

Last updated

2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mood disorder

Interventions

Trade Name: Lexpec Pharmaceutical Form: Pharmaceutical form of the placebo: Syrup Route of administration of the placebo: Oral use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Teenage child of biological parent with mood disorder. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Previous or current history of mood disorder or other Axis I disorder.

Design outcomes

Primary

Measure	Time frame
Main Objective: Prevention of mood disorder in "at-risk" individuals.;Secondary Objective: Decrease in depressive symptoms and improved well-being.; Primary end point(s): Occurence of Axis I mood disorder on DSM-IV diagnostic schedule.	—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026